RACHEL BICKER: Open Payments
NPI 1649989468 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 7 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $708 · 2025 $786
Food & beverage: $786
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 1 | $138 |
| SANOFI US SERVICES INC. | 1 | $132 |
| Phathom Pharmaceuticals, Inc. | 1 | $132 |
| Globus Medical, Inc. | 1 | $130 |
| GENZYME CORPORATION | 1 | $123 |
| Novo Nordisk Inc | 1 | $102 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
Products named: ONPATTRO, AYVAKIT, VOQUEZNA, Senza, KEVZARA, Ozempic.
Industry payments across TX — which companies pay providers there.
